Alok Sonig

CEO, US Generics and Global Head –
Generics R&D & Biosimilars,

Lupin Pharmaceuticals, Inc.

Wed., February 16 | 8:35 a.m.

AAM Chair’s Address

Mr. Alok Sonig is a Global Leader in the Pharmaceuticals and Health Care industry with a proven track record and nearly 23 years of experience. His passion and focus have been on building high performance teams, designing integrated processes, and nurturing networks to deliver industry-leading growth.

Most recently, Alok Sonig was CEO of Developed Markets (US, Canada, Europe, and Japan) at Dr. Reddy’s Labs. He joined Dr. Reddy’s in 2012 and ran their India business (June 2012 – August 2015) before moving back to the U.S. to run their North America business based in Princeton, NJ. He was a member of the global Management Council of Dr. Reddy’s. In his tenure, he grew and stabilized the India and US businesses and orchestrated successful acquisitions of companies and strategically important portfolios. He has focused on integrating R&D and Biosimilar capabilities to help drive organic growth across both branded and generic businesses.

He is a board member and Treasurer of AAM (Association for Accessible Medicines) and represents the industry in helping shape dialogue with key stakeholders.

Prior to Dr. Reddy’s, he spent over 15 years at Bristol-Myers Squibb, where Alok held several positions of increasing responsibilities in General Management, Country leadership roles, Global Strategy, and Marketing, mostly based in the Princeton, NJ area. His last role with BMS was Vice President, Strategy and Business model innovation.

Prior to joining BMS, Alok was based in Washington D.C. and spent his early years as a management consultant working in various industries on strategy and innovation assignments, including health care technology and telecommunications.

He holds a Bachelor’s of Engineering from Punjab Engineering College in India and an M.B.A. from American University, Washington, D.C. Alok is married with two daughters and lives in the Princeton area.